$AVXS AveXis, Inc. Insider Trading Week 44/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AveXis, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AveXis, Inc. in week 44/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 185,614 | |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 106.26 | 70 | 7,438 | 0 | 70 to 0 (-100.00 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 105.02 | 205 | 21,529 | 70 | 275 to 70 (-74.55 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 104.06 | 149 | 15,505 | 275 | 424 to 275 (-35.14 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 102.00 | 42 | 4,284 | 424 | 466 to 424 (-9.01 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 100.70 | 631 | 63,542 | 466 | 1.1 K to 466 (-57.52 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 100.05 | 431 | 43,122 | 1,097 | 1.5 K to 1.1 K (-28.21 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 98.51 | 252 | 24,825 | 1,528 | 1.8 K to 1.5 K (-14.16 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Buy | M | 18.47 | 1,780 | 32,877 | 1,780 | 0 to 1.8 K |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 106.17 | 545 | 57,863 | 1,826,802 | 1.8 M to 1.8 M (-0.03 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 105.40 | 766 | 80,736 | 1,827,347 | 1.8 M to 1.8 M (-0.04 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 104.67 | 1,463 | 153,132 | 1,828,113 | 1.8 M to 1.8 M (-0.08 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 103.16 | 513 | 52,921 | 1,829,576 | 1.8 M to 1.8 M (-0.03 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 102.13 | 1,071 | 109,381 | 1,830,089 | 1.8 M to 1.8 M (-0.06 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.77 | 2,128 | 214,439 | 1,831,160 | 1.8 M to 1.8 M (-0.12 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 100.24 | 6,453 | 646,849 | 1,833,288 | 1.8 M to 1.8 M (-0.35 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 98.85 | 1,278 | 126,330 | 1,839,741 | 1.8 M to 1.8 M (-0.07 %) |
| Nov 03 2017 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 98.04 | 783 | 76,765 | 1,841,019 | 1.8 M to 1.8 M (-0.04 %) |